Tim Hoey

896 citations

23 papers · 685 indexed · h-index 7

Impact in

Oncology top 5%
- Cancer Cells and Metastasis
Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation

Papers in ⓘ

Oncology 11
- Cancer Cells and Metastasis 6
- Cancer Immunotherapy and Biomarkers 3
Cancer Research 5
- Cancer-related molecular mechanisms research 2

Co-authors: John Lewicki (17 shared papers)Austin Gurney (14 shared papers)Lucia Beviglia (4 shared papers)Jorge Aguilar (2 shared papers)Cécile Chartier (3 shared papers)Scott J. Dylla (2 shared papers)Janak Raval (2 shared papers)Sasha Lazetic (2 shared papers)
Journals: Cancer Research (12 papers)PLoS ONE (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Clinical Oncology (1 paper)Science Translational Medicine (1 paper)
Partner nations: United States Canada

In The Last Decade

Tim Hoey

21 papers receiving 674 citations

Peers

Countries citing papers authored by Tim Hoey

Since Specialization

Citations

This map shows the geographic impact of Tim Hoey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Hoey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Hoey more than expected).

Fields of papers citing papers by Tim Hoey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Hoey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Hoey. The network helps show where Tim Hoey may publish in the future.

Co-authors

The 25 scholars most cited alongside Tim Hoey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Hoey Line = papers co-authored together Tim Hoey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy PLoS ONE ·Scott J. Dylla, Lucia Beviglia, In‐Kyung Park, Cécile Chartier, Janak Raval, Lucy Ngan, Kellie Pickell, Jorge Aguilar, Sasha Lazetic, Stephanie Smith‐Berdan, Michael F. Clarke, Tim Hoey, John Lewicki, Austin Gurney	2008	448
2	G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers Oncogene ·Wun Chey Sin, Yaoping Zhang, Wendy Zhong, Sree Adhikarakunnathu, Scott Powers, Tim Hoey, Songzhu An, Jianxin Yang	2004	87
3	Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes eLife ·Francis Grafton, Jaclyn J. Ho, Sara Ranjbarvaziri, Farshad Farshidfar, Anastasiia Budan, Stephanie Steltzer, Mahnaz Maddah, Kevin Loewke, Kristina Green, Snahel Patel, Tim Hoey, Mohammad A. Mandegar	2021	41
4	Correction: Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy PLoS ONE ·Scott J. Dylla, Lucia Beviglia, Inkyung Park, Cécile Chartier, Janak Raval, Lucy Ngan, Kellie Pickell, Jorge Aguilar, Sasha Lazetic, Stephanie Smith‐Berdan, Michael F. Clarke, Tim Hoey, John Lewicki, Austin Gurney	2008	39
5	Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy Science Translational Medicine ·Jin Yang, Francis Grafton, Sara Ranjbarvaziri, Ana Budan, Farshad Farshidfar, Marie Cho, Emma Xu, Jaclyn J. Ho, Mahnaz Maddah, Kevin Loewke, Julio C. Medina, David Sperandio, Snahel Patel, Tim Hoey, Mohammad A. Mandegar	2022	25
6	Abstract 3728: Anti-Notch1 antibody (OMP-52M51) impedes tumor growth and cancer stem cell frequency (CSC) in a chemo-refractory breast cancer xenograft model with an activating Notch1 mutation and screening for activated Notch1 across multiple solid tumor types. Cancer Research ·Belinda Cancilla, Jennifer Cain, Min Wang, Lucia Beviglia, Jalpa Shah, Austin Gurney, John Lewicki, Laura J. Esserman, Tim Hoey, Ann M. Kapoun	2013	9
7	Abstract 2003: Antibody against TIGIT (T cell immunoreceptor with Ig and ITIM domains) induces anti-tumor immune response and generates long-term immune memory Cancer Research ·Angie Inkyung Park, Minu K. Srivastava, Erin Mayes, Hyun-Bae Jie, Rui Yun, Christopher L. Murriel, Ming-Hong Xie, Andrew Lam, May Ji, Fumiko Axelrod, Jorge Monteon, John Lewicki, Tim Hoey, Austin Gurney	2017	8
8	Abstract 2612: Anti-Tigit induces T cell mediated anti-tumor immune response and combines with immune checkpoint inhibitors to enhance strong and long term anti-tumor immunity Cancer Research ·Minu K. Srivastava, Rui Yun, Erin Mayes, Janice Yu, Hyun-Bae Jie, Fumiko Axelrod, Ming-Hong Xie, Jorge Monteon, Andrew Lam, May Ji, Yuwang Liu, John Lewicki, Tim Hoey, Austin Gurney, Angie Inkyung Park	2017	4
9	Abstract 3129: Predictive biomarker identification for response to vantictumab (OMP-18R5; anti-Frizzled) using primary patient-derived human pancreatic tumor xenografts Cancer Research ·Chun Zhang, Fiore Cattaruzza, Pete Yeung, Wan-Ching Yen, Marcus Fischer, Claire Guo, Alayne Brunner, Min Wang, Belinda Cancilla, Austin Gurney, Rainer K. Brachmann, John Lewicki, Tim Hoey, Ann M. Kapoun	2016	3
10	Abstract 4652: Effects of anti-DLL4 treatment on non-small cell lung cancer (NSCLC) human xenograft tumors Cancer Research ·Alayne Brunner, Fiore Cattaruzza, Wan-Ching Yen, Pete Yeung, Marcus Fischer, Belinda Cancilla, Gilbert O’Young, Raymond Tam, Yuwang Liu, Austin Gurney, John Lewicki, Tim Hoey, Min Wang, Ann M. Kapoun	2016	3
11	Paracrine wnt-β-catenin signaling inhibition as a strategy to enhance the efficacy of anti-PD-1 antibody (Ab) therapy in a transgenic model of melanoma. Journal of Clinical Oncology ·Nicholas C. DeVito, Christine Xiao, Fei Zhao, Kathy S. Evans, Bala Theivanthiran, John Lewicki, Tim Hoey, Herbert I. Hurwitz, John H. Strickler, Brent A. Hanks	2017	3
12	Abstract 2834: Anti-DLL4 treatment inhibits melanoma tumor growth, recurrence, metastases, and reduces frequency of cancer stem cells in a clinically relevant tumor model in NOD/SCID mice Cancer Research ·Lucia Beviglia, Pete Yeung, Marcus Fischer, Wang-Ching Yen, John Lewicki, Austin Gurney, Tim Hoey, Ann M. Kapoun	2011	3
13	Abstract 599: Pharmacodynamic biomarkers for anti-TIGIT treatment and prevalence of TIGIT expression in multiple solid tumor types Cancer Research ·Fiore Cattaruzza, Pete Yeung, Min Wang, Alayne Brunner, Erwan Le Scolan, Jennifer Cain, Gretechen Argast, Gilbert O’Young, YuWang Liu, Belinda Cancilla, Austin Gurney, Tim Hoey, John Lewicki, Ann M. Kapoun	2017	2
14	Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses Journal for ImmunoTherapy of Cancer ·Minu K. Srivastava, Christopher L. Murriel, Rui Yun, Erin Mayes, Hyun-Bae Jie, Fumiko Axelrod, Ming-Hong Xie, Trevor Bentley, Belinda Cancilla, Raymond Tam, Gilbert O’Young, Ann M. Kapoun, John Lewicki, Tim Hoey, Austin Gurney, Park Angie Inkyung	2015	2
15	Abstract A30: Predictive and pharmacodynamic biomarkers of vantictumab (OMP-18R5; anti-Frizzled) in non-small cell lung cancer Molecular Cancer Therapeutics ·Chun Zhang, Fiore Cattaruzza, Pete Yeung, Wan-Ching Yen, Marcus Fischer, Alayne Brunner, Min Wang, Belinda Cancilla, Rainer K. Brachmann, Tim Hoey, John Lewicki, Ann M. Kapoun	2015	2
16	Abstract 213: Novel NOTCH3 activating mutations identified in tumors sensitive to OMP-59R5, a monoclonal antibody targeting the Notch2 and Notch3 receptors. Cancer Research ·Breanna Wallace, Min Wang, Chris Muriel, Jennifer Cain, Belinda Cancilla, Jalpa Shah, Jie Wei, Austin Gurney, John Lewicki, Aaron K. Sato, Tim Hoey, Tracy Tang, Ann M. Kapoun	2013	1
17	Abstract 4367: Discovery and evaluation of pharmacodynamic and predictive biomarkers for anti-RSPO3, a treatment that reduces tumor growth and cancer stem cell frequency in patient derived xenograft tumor models Cancer Research ·Fiore Cattaruzza, Pete Yeung, Wan-Ching Yen, Alayne Brunner, Min Wang, YuWang Liu, Marcus Fischer, Gilbert O’Young, Cécile Chartier, Austin Gurney, Tim Hoey, John Lewicki, Ann M. Kapoun	2015	1
18	Abstract 255: Dual targeting of Delta-like ligand 4 (DLL4) and programmed death 1(PD1) inhibits tumor growth and generates enhanced long-term immunological memory Cancer Research ·Minu K. Srivastava, Christopher L. Murriel, Julie M. Roda, Hyun-Bae Jie, Fumiko Axelrod, Ming-Hong Xie, Rui Yun, Erin Mayes, Trevor Bentley, Belinda Cancilla, Raymond Tam, Tracy Tang, Ann M. Kapoun, John Lewicki, Tim Hoey, Austin Gurney, Angie Inkyung Park	2015	1
19	Simply C#: An Application-Driven Tutorial Approach CERN Document Server (European Organization for Nuclear Research) ·Harvey M. Deitel, Paul J. Deitel, Tim Hoey, Cheryl H. Yaeger	2003	1
20	Abstract 404: Development of a RSPO3 CLIA-validated assay as a predictive biomarker for response to anti-RSPO3 antibody treatment in patients with solid tumors Cancer Research ·Chun Zhang, Yuwang Liu, Min Wang, Gilbert O’Young, Joy N. Kavanagh, Cheryl McFarlane, Fiore Cattaruzza, Pete Yeung, Jennifer Cain, Wan-Ching Yen, Marcus Fischer, Belinda Cancilla, Edwina Dobbin, Michelle McCarthy, Austin Gurney, Leonardo Faoro, John Lewicki, Tim Hoey, Ann M. Kapoun	2016	1

About Tim Hoey

Tim Hoey is a scholar working on Oncology, Cancer Research, Immunology, Immunology and Allergy and Molecular Biology, having authored 23 papers that have together received 685 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nanoplatforms for cancer theranostics (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Oncology (456 citations), Cancer Research (182 citations), Biotechnology (58 citations), Molecular Biology (408 citations) and Cell Biology (51 citations). Tim Hoey has collaborated with scholars based in United States and Canada. Frequent co-authors include John Lewicki, Austin Gurney, Lucia Beviglia, Jorge Aguilar, Cécile Chartier, Scott J. Dylla, Janak Raval, Sasha Lazetic, Michael F. Clarke and Stephanie Smith‐Berdan. Their work appears in journals such as Cancer Research, PLoS ONE, Molecular Cancer Therapeutics, Journal of Clinical Oncology and Science Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact